Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3543)
All Articles published online
|
Mar 14, 2005 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Li HG, Xie DR, Shen XM, Li HH, Zeng H, Zeng YJ. Clinicopathological significance of expression of paxillin, syndecan-1 and EMMPRIN in hepatocellular carcinoma. World J Gastroenterol 2005; 11(10): 1445-1451 [PMID: 15770719 DOI: 10.3748/wjg.v11.i10.1445] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i10/1445.htm |
| Number | Citing Articles |
| 1 |
Wei Wu, Rongbing Wang, Hui Liu, Jie Peng, Damao Huang, Bo Li, Jingde Ruan. Prediction of prognosis in gallbladder carcinoma by CD147 and MMP-2 immunohistochemistry. Medical Oncology 2009; 26(2): 117 doi: 10.1007/s12032-008-9087-6
|
| 2 |
Shinichi Sakamoto, Richard O. McCann, Rajiv Dhir, Natasha Kyprianou. Talin1 Promotes Tumor Invasion and Metastasis via Focal Adhesion Signaling and Anoikis Resistance. Cancer Research 2010; 70(5): 1885 doi: 10.1158/0008-5472.CAN-09-2833
|
| 3 |
Jean-Charles Nault, Erwan Guyot, Christelle Laguillier, Sylvie Chevret, Nathalie Ganne-Carrie, Gisèle N'Kontchou, Michel Beaugrand, Olivier Seror, Jean-Claude Trinchet, Jessica Coelho, Philippe Lasalle, Nathalie Charnaux, Maryse Delehedde, Angela Sutton, Pierre Nahon. Serum Proteoglycans as Prognostic Biomarkers of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis. Cancer Epidemiology, Biomarkers & Prevention 2013; 22(8): 1343 doi: 10.1158/1055-9965.EPI-13-0179
|
| 4 |
Li Zhong, Sarah P. Coe, Arnold J. Stromberg, Nada H. Khattar, James R. Jett, Edward A. Hirschowitz. Profiling Tumor-Associated Antibodies for Early Detection of Non-small Cell Lung Cancer. Journal of Thoracic Oncology 2006; 1(6): 513 doi: 10.1016/S1556-0864(15)30352-X
|
| 5 |
Jiayi Cao, Suzhen Yang, Tingting Luo, Rui Yang, Hanlong Zhu, Tianming Zhao, Kang Jiang, Bing Xu, Yingchun Wang, Fulin Chen. TATA-box-binding protein promotes hepatocellular carcinoma metastasis through epithelial-mesenchymal transition. Hepatology Communications 2023; 7(7) doi: 10.1097/HC9.0000000000000155
|
| 6 |
Zhao-dong Han, Xue-cheng Bi, Wei-jun Qin, Hui-chan He, Qi-shan Dai, Jun Zou, Yong-kang Ye, Yu-xiang Liang, Guo-hua Zeng, Zhi-nan Chen, Wei-de Zhong. CD147 Expression Indicates Unfavourable Prognosis in Prostate Cancer. Pathology & Oncology Research 2009; 15(3): 369 doi: 10.1007/s12253-008-9131-z
|
| 7 |
Hua-chuan Zheng, Wei Wang, Xiao-yan Xu, Pu Xia, Miao Yu, Toshiro Sugiyama, Yasuo Takano. Up-regulated EMMPRIN/CD147 protein expression might play a role in colorectal carcinogenesis and its subsequent progression without an alteration of its glycosylation and mRNA level. Journal of Cancer Research and Clinical Oncology 2011; 137(4): 585 doi: 10.1007/s00432-010-0919-3
|
| 8 |
Nahoko Tomonobu, Rie Kinoshita, Masakiyo Sakaguchi. S100 Soil Sensor Receptors and Molecular Targeting Therapy Against Them in Cancer Metastasis. Translational Oncology 2020; 13(4): 100753 doi: 10.1016/j.tranon.2020.100753
|
| 9 |
Kathryn T. Iacono, Amy L. Brown, Mark I. Greene, Sandra J. Saouaf. CD147 immunoglobulin superfamily receptor function and role in pathology. Experimental and Molecular Pathology 2007; 83(3): 283 doi: 10.1016/j.yexmp.2007.08.014
|
| 10 |
Zhao-dong Han, Hui-chan He, Xue-cheng Bi, Wei-jun Qin, Qi-shan Dai, Jun Zou, Yong-kang Ye, Yu-xiang Liang, Guo-hua Zeng, Gang Zhu, Zhi-nan Chen, Wei-de Zhong. Expression and Clinical Significance of CD147 in Genitourinary Carcinomas. Journal of Surgical Research 2010; 160(2): 260 doi: 10.1016/j.jss.2008.11.838
|
| 11 |
Wulf Sienel, Bernhard Polzer, Karimah Elshawi, Michael Lindner, Alicia Morresi-Hauf, Christian Vay, Fabian Eder, Bernward Passlick, Christoph A Klein. Cellular localization of EMMPRIN predicts prognosis of patients with operable lung adenocarcinoma independent from MMP-2 and MMP-9. Modern Pathology 2008; 21(9): 1130 doi: 10.1038/modpathol.2008.102
|
| 12 |
Alexander C Mackinnon, Maria Tretiakova, Les Henderson, Rajendra G Mehta, Benjamin C Yan, Loren Joseph, Thomas Krausz, Aliya N Husain, Mary E Reid, Ravi Salgia. Paxillin expression and amplification in early lung lesions of high-risk patients, lung adenocarcinoma and metastatic disease. Journal of Clinical Pathology 2011; 64(1): 16 doi: 10.1136/jcp.2010.075853
|
| 13 |
Xianchen Liu, Dong Xu, Xiaodong Xu, Qiang Xue, Xuesong Gao, Chong Tang. MiR-216b regulates the tumorigenesis of gastric cancer by targeting PXN. Pathology - Research and Practice 2021; 218: 153325 doi: 10.1016/j.prp.2020.153325
|
| 14 |
Xiaoyan Xin, Xianqin Zeng, Huajian Gu, Min Li, Huaming Tan, Zhishan Jin, Teng Hua, Rui Shi, Hongbo Wang. CD147/EMMPRIN overexpression and prognosis in cancer: A systematic review and meta-analysis. Scientific Reports 2016; 6(1) doi: 10.1038/srep32804
|
| 15 |
Yasuo Tanaka, Ryosuke Tateishi, Kazuhiko Koike. Proteoglycans Are Attractive Biomarkers and Therapeutic Targets in Hepatocellular Carcinoma. International Journal of Molecular Sciences 2018; 19(10): 3070 doi: 10.3390/ijms19103070
|
| 16 |
H-C Zheng, H Takahashi, Y Murai, Z-G Cui, K Nomoto, S Miwa, K Tsuneyama, Y Takano. Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis. British Journal of Cancer 2006; 95(10): 1371 doi: 10.1038/sj.bjc.6603425
|
| 17 |
Michele C. Madigan, Elizabeth A. Kingsley, Paul J. Cozzi, Warick J. Delprado, Pamela J. Russell, Yong Li. The role of extracellular matrix metalloproteinase inducer protein in prostate cancer progression. Cancer Immunology, Immunotherapy 2008; 57(9): 1367 doi: 10.1007/s00262-008-0473-x
|
| 18 |
Justyna Szumilo, Franciszek Burdan, Krzysztof Zinkiewicz, Jaroslaw Dudka, Robert Klepacz, Andrzej Dabrowski, Elzbieta Korobowicz. Expression of syndecan-1 and cathepsins D and K in advanced esophageal squamous cell carcinoma.. Folia Histochemica et Cytobiologica 2010; 47(4) doi: 10.2478/v10042-008-0012-8
|
| 19 |
Attila Patonai, Boglárka Erdélyi-Belle, Anna Korompay, Áron Somorácz, Péter Törzsök, Ilona Kovalszky, Tamás Barbai, Erzsébet Rásó, Gábor Lotz, Zsuzsa Schaff, András Kiss. Molecular Characteristics of Fibrolamellar Hepatocellular Carcinoma. Pathology & Oncology Research 2013; 19(1): 63 doi: 10.1007/s12253-012-9558-0
|
| 20 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_181-1
|
| 21 |
Min Gong. Expression of Paxillin is Correlated with Clinical Prognosis in Colorectal Cancer Patients. Medical Science Monitor 2015; 21: 1989 doi: 10.12659/MSM.893832
|
| 22 |
Li Zhong, Sarah P. Coe, Arnold J. Stromberg, Nada H. Khattar, James R. Jett, Edward A. Hirschowitz. Profiling Tumor-Associated Antibodies for Early Detection of Non-small Cell Lung Cancer. Journal of Thoracic Oncology 2006; 1(6): 513 doi: 10.1097/01243894-200607000-00003
|
| 23 |
John R. Couchman. Syndecan-1 (CD138), Carcinomas and EMT. International Journal of Molecular Sciences 2021; 22(8): 4227 doi: 10.3390/ijms22084227
|
| 24 |
Cory D. Bovenzi, James Hamilton, Patrick Tassone, Jennifer Johnson, David M. Cognetti, Adam Luginbuhl, William M. Keane, Tingting Zhan, Madalina Tuluc, Voichita Bar-Ad, Ubaldo Martinez-Outschoorn, Joseph M. Curry. Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/242437
|
| 25 |
Faten Charni, Veronique Friand, Oualid Haddad, Hanna Hlawaty, Loïc Martin, Roger Vassy, Olivier Oudar, Liliane Gattegno, Nathalie Charnaux, Angela Sutton. Syndecan-1 and syndecan-4 are involved in RANTES/CCL5-induced migration and invasion of human hepatoma cells. Biochimica et Biophysica Acta (BBA) - General Subjects 2009; 1790(10): 1314 doi: 10.1016/j.bbagen.2009.07.015
|
| 26 |
Weichen Zhou, Yanyun Ma, Jun Zhang, Jingyi Hu, Menghan Zhang, Yi Wang, Yi Li, Lijun Wu, Yida Pan, Yitong Zhang, Xiaonan Zhang, Xinxin Zhang, Zhanqing Zhang, Jiming Zhang, Hai Li, Lungen Lu, Li Jin, Jiucun Wang, Zhenghong Yuan, Jie Liu. Predictive model for inflammation grades of chronic hepatitis B: Large‐scale analysis of clinical parameters and gene expressions. Liver International 2017; 37(11): 1632 doi: 10.1111/liv.13427
|
| 27 |
Yang Zhao, Shuo Chen, Wen-feng Gou, Zhe-feng Niu, Shuang Zhao, Li-jun Xiao, Yasuo Takano, Huachuan Zheng. The role of EMMPRIN expression in ovarian epithelial carcinomas. Cell Cycle 2013; 12(17): 2899 doi: 10.4161/cc.25950
|
| 28 |
Dong-liang Chen, Zhi-qiang Wang, Chao Ren, Zhao-lei Zeng, De-shen Wang, Hui-yan Luo, Feng Wang, Miao-zhen Qiu, Long Bai, Dong-sheng Zhang, Feng-hua Wang, Yu-hong Li, Rui-hua Xu. Abnormal expression of paxillin correlates with tumor progression and poor survival in patients with gastric cancer. Journal of Translational Medicine 2013; 11(1) doi: 10.1186/1479-5876-11-277
|
| 29 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_185-1
|
| 30 |
Xiaoli Zhang, Yalei Zhao, Liangru Liu, Yingli He. Syndecan-1: A Novel Diagnostic and Therapeutic Target in Liver Diseases. Current Drug Targets 2023; 24(15): 1155 doi: 10.2174/0113894501250057231102061624
|
| 31 |
Jun-li Si, Yu-qin Qi, Jing-yuan Cui, Song-mei Wang, He Wang, Mei Lü. Detection of Syndecan-1 and heparanase-1 genes in esophageal carcinoma by quantitative RT-PCR. Clinical Oncology and Cancer Research 2010; 7(4): 253 doi: 10.1007/s11805-010-0527-7
|
| 32 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 3409 doi: 10.1007/978-3-319-26956-6_185
|
| 33 |
Judy Wai Ping Yam, Frankie Chi Fat Ko, Chung‐Yiu Chan, Tai‐On Yau, Edmund Kwok Kwan Tung, Thomas Ho‐Yin Leung, Dong‐Yan Jin, Irene Oi‐Lin Ng. Tensin2 variant 3 is associated with aggressive tumor behavior in human hepatocellular carcinoma†. Hepatology 2006; 44(4): 881 doi: 10.1002/hep.21339
|
| 34 |
Dong-Liang Chen, De-Shen Wang, Wen-Jing Wu, Zhao-Lei Zeng, Hui-Yan Luo, Miao-Zhen Qiu, Chao Ren, Dong-Sheng Zhang, Zhi-Qiang Wang, Feng-Hua Wang, Yu-Hong Li, Tie-Bang Kang, Rui-Hua Xu. Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer. Carcinogenesis 2013; 34(4): 803 doi: 10.1093/carcin/bgs400
|
| 35 |
Fei Peng, Hui Li, Qian You, Hongru Li, Dongwen Wu, Chunxiang Jiang, Guangtong Deng, Yan Li, Yuyan Li, Yi Wu. CD147 as a Novel Prognostic Biomarker for Hepatocellular Carcinoma: A Meta-Analysis. BioMed Research International 2017; 2017: 1 doi: 10.1155/2017/5019367
|
| 36 |
Qing Zhang, Jun Zhou, Xiao-Ming Ku, Xin-Guo Chen, Li Zhang, Jing Xu, Guang-Sheng Chen, Qin Li, Feng Qian, Rong Tian, Ning Wen, Zhi-Nan Chen. Expression of CD147 as a significantly unfavorable prognostic factor in hepatocellular carcinoma. European Journal of Cancer Prevention 2007; 16(3): 196 doi: 10.1097/01.cej.0000236245.40619.c3
|
| 37 |
Daniel R. Boutz, Patrick J. Collins, Uthra Suresh, Mingzhu Lu, Cristina M. Ramírez, Carlos Fernández-Hernando, Yufei Huang, Raquel de Sousa Abreu, Shu-Yun Le, Bruce A. Shapiro, Angela M. Liu, John M. Luk, Shelley Force Aldred, Nathan D. Trinklein, Edward M. Marcotte, Luiz O.F. Penalva. Two-tiered Approach Identifies a Network of Cancer and Liver Disease-related Genes Regulated by miR-122. Journal of Biological Chemistry 2011; 286(20): 18066 doi: 10.1074/jbc.M110.196451
|
| 38 |
Vikas Patil, Kulandaivelu Mahalingam. A four-protein expression prognostic signature predicts clinical outcome of lower-grade glioma. Gene 2018; 679: 57 doi: 10.1016/j.gene.2018.08.001
|
| 39 |
Z. C. Song, R. Shu, X. L. Zhang. Cellular responses and expression profiling of human bone marrow stromal cells stimulated with enamel matrix proteins in vitro. Cell Proliferation 2010; 43(1): 84 doi: 10.1111/j.1365-2184.2009.00656.x
|
| 40 |
Yushuang Zheng, Miao Yu, Huachuan Zheng, Yifu Guan, Yasuo Takano. Pulmonary large cell carcinoma displays high expression of EMMPRIN and VEGF. Chinese Journal of Clinical Oncology 2008; 5(5): 333 doi: 10.1007/s11805-008-0333-7
|
| 41 |
Wei Gao, Chunming Zhang, Yan Feng, Ganggang Chen, Shuxin Wen, Hui Huangfu, Binquan Wang, Adam I. Marcus. Fascin-1, Ezrin and Paxillin Contribute to the Malignant Progression and Are Predictors of Clinical Prognosis in Laryngeal Squamous Cell Carcinoma. PLoS ONE 2012; 7(11): e50710 doi: 10.1371/journal.pone.0050710
|
| 42 |
Li Zhong, Giovanna E. Hidalgo, Arnold J. Stromberg, Nada H. Khattar, James R. Jett, Edward A. Hirschowitz. Using Protein Microarray as a Diagnostic Assay for Non–Small Cell Lung Cancer. American Journal of Respiratory and Critical Care Medicine 2005; 172(10): 1308 doi: 10.1164/rccm.200505-830OC
|
| 43 |
Motonari Ohashi, Tomomi Kusumi, Fuyuki Sato, Yasuyuki Kudo, Hiroyuki Jin, Harue Akasaka, Keiichi Miyamoto, Yoshikazu Toyoki, Kenichi Hakamada, Hiroshi Kijima. Expression of syndecan-1 and E-cadherin is inversely correlated with poor patient's prognosis and recurrent status of extrahepatic bile duct carcinoma. Biomedical Research 2009; 30(2): 79 doi: 10.2220/biomedres.30.79
|
| 44 |
Daisuke Furukawa, Tsuyoshi Chijiwa, Masahiro Matsuyama, Masaya Mukai, Ei-Ichi Matsuo, Osamu Nishimura, Kenji Kawai, Hiroshi Suemizu, Toshio Nakagohri, Soji Ozawa, Kazuaki Shimada, Nobuyoshi Hiraoka, Masato Nakamura. Plasma membrane expression of ZNF185 is a prognostic factor in pancreatic ductal carcinoma. Oncology Letters 2017; 14(3): 3633 doi: 10.3892/ol.2017.6633
|
| 45 |
Hui Tan, Ke Ye, Zhiming Wang, Huihuan Tang. CD147 expression as a significant prognostic factor in differentiated thyroid carcinoma. Translational Research 2008; 152(3): 143 doi: 10.1016/j.trsl.2008.07.005
|
| 46 |
LI-JUN XIAO, EN-HONG ZHAO, SHUANG ZHAO, XIN ZHENG, HUA-CHUAN ZHENG, YASUO TAKANO, HONG-RU SONG. Paxillin expression is closely linked to the pathogenesis, progression and prognosis of gastric carcinomas. Oncology Letters 2014; 7(1): 189 doi: 10.3892/ol.2013.1686
|
| 47 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 3323 doi: 10.1007/978-3-319-26956-6_181
|
| 48 |
Yin Hongfang, Zhang Quanwen, Wang Xin, Li Ting, Wan Yuanlian, Liu Yucun, Zhu Jing. Role of paxillin in colorectal carcinoma and its relationship to clinicopathological features. Chinese Medical Journal 2014; 127(3): 423 doi: 10.3760/cma.j.issn.0366-6999.20121360
|
| 49 |
Péter Hollósi, Lóránd Váncza, Katalin Karászi, Katalin Dobos, Bálint Péterfia, Enikő Tátrai, Péter Tátrai, Tibor Szarvas, Sándor Paku, László Szilák, Ilona Kovalszky. Syndecan-1 Promotes Hepatocyte-Like Differentiation of Hepatoma Cells Targeting Ets-1 and AP-1. Biomolecules 2020; 10(10): 1356 doi: 10.3390/biom10101356
|